| Epilepsy News From Medical News Today |
Research Study Opens The Door To New Class Of Drugs For Epileptic Seizures A chemical compound that boosts the action of a molecule normally produced in the brain may provide the starting point for a new line of therapies for the treatment of epileptic seizures, according to a new study by scientists at The Scripps Research Institute... |
Certain Epilepsy Drugs May Increase Risk Of Suicide While the Food and Drug Administration (FDA) requires a warning of an increased risk of suicide for all epilepsy drugs, a new study shows that only certain drugs may increase the risk. The study is published in the July 27, 2010, issue of Neurology®, the medical journal of the American Academy of Neurology... |
Women Help Women Live And Cope With Epilepsy In The Family A new campaign explores the roles and responsibilities women uniquely encounter when living, or caring for a loved one, with epilepsy. "Women Succeeding with Epilepsy" is a collaboration between Epilepsy Advocate and HealthyWomen to educate, empower and inspire women and families whose lives are affected by epilepsy... |
FDA Accepts Historical Controls For Epilepsy Monotherapy Studies New York University researchers revealed that data from previously completed withdrawal to monotherapy studies for antiepileptic drugs (AEDs) provide a valid control for future studies, obviating the need for placebo/pseudo-placebo trials to demonstrate the efficacy of these drugs as monotherapy... |
FDA Accepts BANZEL(R) (Rufinamide) Oral Suspension NDA For Review Eisai Inc. (Headquarters: Woodcliff Lake, NJ; President and CEO: Lonnel Coats), a U.S. subsidiary of Eisai Co., Ltd. (Headquarters: Tokyo; President and CEO: Haruo Naito) announced that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's NDA for BANZEL® (rufinamide) Oral Suspension (40 mg/mL)... |
Soldiers With Brain Injuries At Higher Risk Of Epilepsy Decades Later Soldiers who receive traumatic brain injuries during war may be at a higher risk of epilepsy even decades after the brain injury occurred. The new research is published in the July 20, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology... |
Research Project Analyses Cerebral Bioelectricity In Order To Detect Epilepsy A group of researchers from Universidad Carlos III de Madrid (UC3M) has presented a new algorithm that uses a new method to analyse the information obtained from electroencephalograms to detect neurodegenerative diseases, such as epilepsy, using the bioelectric signals of the brain... |
NeuroPace Submits PMA Application For FDA Approval Of Novel Investigational Device For Epilepsy NeuroPace, Inc. announced that it has submitted its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its RNS® System, a novel investigational device that utilizes responsive neurostimulation to monitor and interrupt abnormal electrical activity in the brain before seizures occur... |
Epilepsy Nurses Encouraged To Take The Right Path, UK A new learning and development pathway programme has been produced for Nurses working at the National Centre for Young People with Epilepsy (NCYPE). The national epilepsy charity has a world class medical centre - the Neville Childhood Epilepsy Centre - as part of its 60 acre campus in Lingfield, Surrey... |
New Data For Vimpat (Lacosamide) C-V Showed Sustained Efficacy For Up To 5 Years New long term data showed that Vimpat® (lacosamide) C-V provided sustained reduction in seizure frequency for up to five years when used as an add-on treatment for uncontrolled partial onset seizures in adults with epilepsy... |
| RSS integration by RSSinclude |